home / stock / nbrv / nbrv news

NBRV News and Press, Nabriva Therapeutics plc From 06/07/19

Stock Information
Company Name: Nabriva Therapeutics plc
Stock Symbol: NBRV
Market: NASDAQ
Menu
NBRV NBRV Quote NBRV Short NBRV News NBRV Articles NBRV Message Board
Get NBRV Alerts

News, Short Squeeze, Breakout and More Instantly...
NBRV - Antimicrobials Working Group Commends Senator Isakson and Senator Casey for Introducing Legislation to Improve Access to Innovative Therapies to Fight Drug-Resistant Infections

The DISARM Act of 2019 provides the framework needed to stabilize the antimicrobial ecosystem, spur development of new infection-fighting drugs, and preserve the effectiveness of existing medicines for drug-resistant infections WASHINGTON , June 7, 2019 /PRNewswire/ -- The Antimi...
NBRV - Nabriva Therapeutics to Present at the Jefferies 2019 Healthcare Conference

DUBLIN, Ireland and KING OF PRUSSIA, Pa., May 22, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, today announced that Ted Schroeder, Chief Executive...

NBRV - LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Nabriva Therapeutics plc To Contact The Firm

NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Nabriva Therapeutics plc (“Nabriva” or the “Company”) (NASDAQ:NBRV) of the July 8, 2019 deadline to seek the role of lead plaintiff i...

NBRV - Nabriva Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights

DUBLIN, Ireland, May 10, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, today announced its financial results for the three months ended March 31, 2019 ...
NBRV - Nabriva Therapeutics to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference

DUBLIN, Ireland and KING OF PRUSSIA, Pa., May 08, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, today announced that Ted Schroeder, Chief Executive...

NBRV - Nabriva Therapeutics Announces Submission of Marketing Authorization Application for Lefamulin to Treat Community-Acquired Pneumonia in Adults by European Medicines Agency

DUBLIN, Ireland, May 08, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, announced that the Company’s  marketing authorization application ...

NBRV - Glancy Prongay & Murray LLP Announces Investigation on Behalf of Nabriva Therapeutics plc Investors

Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Nabriva Therapeutics plc (“Nabriva” or the “Company”) (NASDAQ: NBRV ) investors concerning the Company and its officers’ possible violations of federal securiti...
NBRV - Nabriva Investigated by Block & Leviton LLP For Violations of Federal Securities Laws

BOSTON, May 02, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP ( www.blockesq.com ), a national securities litigation firm, is investigating whether Nabriva Therapeutics plc (“Nabriva” or the “Company”) (NASDAQ: NBRV) and certain of its officers and directors...

NBRV - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Nabriva Therapeutics PLC (NBRV)

NEW YORK, NY / ACCESSWIRE / May 2, 2019 / Bronstein, Gewirtz & Grossman, LLC isinvestigating potential claims on behalf of purchasers of Nabriva Therapeutics PLC ("Nabriva" or the "Company") (NASDAQ: NBRV). Such investors are encouraged to obtain additional information and assist the inv...

NBRV - FTR, NUS, PBI and ENPH among midday movers

Gainers:  ARCA biopharma (NASDAQ: ABIO ) +37% . MFC Bancorp (NYSE: MFCB ) +32% . Enphase Energy (NASDAQ: ENPH ) +29% . Precipio (NASDAQ: PRPO ) +25% . Nu Skin Enterprises (NYSE: NUS ) +25% . Nanometrics Incorporated (NASDAQ: NANO ) +22% . Qumu Corporation (NASDAQ: QUMU ) +22% ....
Previous 10 Next 10